These companies have been implementing various strategies that have helped the growth of the company and in turn, have brought about various changes in the market. The companies have utilized strategies such as product launches, expansions, and product upgrades for the growth of their organizations. For instance, In Mar 2021, Abbott launched NeuroSphere Virtual Clinic in the US, a first-of-its-kind technology enabling patients to interact with physicians, ensure proper functionality and settings, and receive new treatment settings remotely as per requirement. The NeuroSphere Virtual Clinic can extend access to optimal treatment for patients with movement disorders or chronic pain who don’t live near a care provider, who cannot access care easily, or are unable to visit a physician due to circumstances such as COVID-19.
Boston Scientific Corporation and Medtronic – are Notable Market Players in Global Nerve Repair & Regeneration Market
Nerves along with the brain and spinal cord, are the foundation of nervous system. Nerve repair is method which involves exploration of the injured nerve and removal of injured tissue or scar from the nerve endings. While nerve regeneration refers to the regrowth or repair of nervous tissues, cells or cell products. Regeneration mechanism may include generation of new neurons, glia, axons, myelin, or synapses. The nerve repair & regeneration is carried out by various products which includes neurostimulation & neuromodulation devices and biomaterials such as nerve conduits, nerve wraps, nerve connectors, and other biomaterials.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the global nerve repair & regeneration market, including Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV. The companies have been implementing various strategies that have helped the growth of the company and in turn, have brought about various changes in the market. The companies have utilized organic strategies such as launches and product approvals. Whereas inorganic strategies such as mergers & acquisitions, and collaborations, were widely seen in the market.
Several organic approaches, such as product launches, and expansion in the US and Europe nerve repair & regeneration market, have resulted in the positive growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies adopted by the players operating in the US and Europe nerve repair & regeneration market:
| YEAR | NEWS |
| July-2022 | Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the strength of the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future |
| April-2022 | Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for its latest image-guided programming software, Vercise Neural Navigator with STIMVIEW XT. The product is developed in collaboration with Brainlab AG. STIMVIEW XT allows physicians, in real-time, the capacity to visualize both stimulation modeling and lead placement of the brain anatomy of their patients having an essential tremor or Parkinson’s disease. |
| March 2022 | Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant to repair peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits alone. |
